Showing recent highlights
What's New
PubMed (Open Access Guidelines) · December 1, 2026
Researchers found that allergen immunotherapy — a treatment that gradually exposes the immune system to small amounts of a trigger like dust mites or grass pollen to reduce sensitivity — helped people with allergic asthma breathe better and rely less on medication. Shots (given under the skin) appeared to work better than drops or tablets placed under the tongue, and the treatment seemed to help both children and adults fairly equally. However, the shot-based approach did cause more whole-body reactions, like hives or swelling, so that's something patients would want to discuss with their doctor. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 3, 2026
Researchers found that children with asthma who practiced daily breathing exercises specifically focused on strengthening the muscles used when breathing out — called expiratory muscle training — saw bigger improvements in lung function, physical endurance, and overall asthma control compared to children who did a standard chest physiotherapy program alone. These exercises were done once a day for 8 weeks, and kids in the training group also showed stronger breathing muscles and better cough strength, which helps clear the airways. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers gave people with hard-to-control asthma a synbiotic — a supplement that combines probiotics (good bacteria) and prebiotics (food that feeds those bacteria) — and found that it appeared to reduce airway inflammation and make it easier for air to flow in and out of the lungs. This is exciting because it suggests that balancing the bacteria in the body might one day play a role in managing asthma symptoms, which affects millions of people worldwide. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that children having severe asthma attacks in the emergency room were much less likely to need a hospital stay when they received their breathing medication through a new device called SOBIstat-F — about 9% were hospitalized compared to 27% with the standard method. Kids using the new device also showed faster breathing improvement and better oxygen levels in their blood (a measure of how well oxygen is getting to the body). This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
A study found that special injectable medications called biologics — which target the immune system's overreaction that drives severe asthma — can significantly cut down on asthma attacks, hospital visits, and the need for steroid pills. Researchers found that doctors can use certain blood tests and breathing tests to help figure out which patients are most likely to benefit from these treatments. The study also noted that cost and access to these medications can be barriers, so it may be worth asking a doctor whether any of these options could be a good fit and whether financial assistance programs are available.
Ask your doctor: Ask the doctor whether the patient might be a good candidate for a biologic medication like Xolair or Dupilumab that targets the immune system to control asthma, based on the patient's current asthma severity and test results.
What's New
PubMed · June 1, 2026
Researchers found that a new experimental pill called BI 894416, which works by blocking a protein involved in inflammation (called spleen tyrosine kinase), appeared to be safe and well-tolerated in both healthy people and those with mild asthma, with only mild side effects like headache, diarrhea, and nausea reported. The study also found that the drug seemed to affect certain immune cells and airway cells in ways that could potentially help reduce asthma-related inflammation. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that people with asthma who used telemedicine — things like remote monitoring, online education, or a combination of both — had better asthma control and quality of life compared to those receiving only standard in-person care. Tele-monitoring, where patients track and share their symptoms or breathing measurements with their care team from home, showed especially strong results for keeping asthma under control. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that a new injectable medication called SHR-1703, designed for people with a type of asthma driven by an overactive immune response, quickly reduced a key trigger of airway inflammation — specific immune cells called eosinophils (a type of white blood cell that can cause asthma flares) — by more than half within just one day, with the effect lasting over 100 days. The medication appeared to be well-tolerated, meaning most side effects were mild and occurred at similar rates to people who received a placebo (a dummy treatment with no active ingredient). This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that when school nurses led programs specifically designed to help students manage their asthma, children experienced fewer symptoms, used their medications more effectively, and felt better overall in their daily lives. The programs that worked best combined ongoing care, hands-on support from nurses, and teamwork between nurses, families, and doctors. However, it's still unclear whether these programs reduce emergency room visits, hospital stays, or missed school days, so more research is needed to answer those questions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 1, 2026
Researchers found that adults with moderate-to-severe asthma who combined aerobic exercise with breathing techniques were able to walk noticeably farther and reported a better quality of life compared to those who didn't do this type of training. Adding exercises that strengthen the breathing muscles appeared to bring extra benefits on top of that. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · June 1, 2026
A study found that tezepelumab (brand name Tezspire), given as an injection every four weeks, helped adults with severe asthma who depended on daily steroid pills — like prednisone — reduce how much of those pills they needed to take. Researchers were testing whether the medication could act as a 'steroid-sparing' treatment, meaning it might help people control their asthma while relying less on long-term steroid use, which can cause side effects over time. This appears to be a look at tezepelumab as a newer option for a particularly difficult-to-treat group of asthma patients, though the study was ended before all planned participants were enrolled, which may affect how definitive the results are.
Ask your doctor: Ask the doctor whether tezepelumab (Tezspire) might help the patient take less of the oral corticosteroids they currently need for asthma control.
What's New
PubMed · May 29, 2026
Researchers found that children with asthma who took montelukast (a common asthma pill) alongside their inhaled steroid medication showed better breathing and asthma control than those who used the inhaled steroid alone — and the combination also appeared to shift the mix of bacteria living in their nose and gut in ways that may help calm the immune system. The connection seems to involve tiny molecules called short-chain fatty acids, which are produced by gut bacteria and may help reduce airway inflammation, the swelling and irritation inside the airways that makes asthma worse. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · May 22, 2026
Researchers found that spending time in underground salt caves — a therapy called speleotherapy — may help people with asthma breathe better and feel more in control of their symptoms. Over three weeks, people with asthma who did six two-hour underground sessions reported improvements in how well they could manage their asthma day-to-day, compared to those who only continued their usual treatment. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · May 19, 2026
Researchers found that adding a type of inhaled bronchodilator medication — called a long-acting muscarinic antagonist, or LAMA — to an existing combination of asthma inhalers may help people with asthma who smoke. The study looked at whether patients who received three inhaled medications together did better than those who received just two, measuring things like lung function (how well air moves in and out of the lungs) and how well their asthma was controlled day-to-day. This appears to be a look at a treatment option for a specific group — people with asthma who smoke — rather than a safety update or a guideline recommendation.
Ask your doctor: Ask the doctor whether a long-acting muscarinic antagonist like Spiriva might help better control the patient's asthma symptoms if the patient smokes.
What's New
PubMed · May 14, 2026
Researchers found that giving vitamin D supplements to children with asthma did raise their vitamin D levels in the blood, but it didn't clearly reduce asthma flare-ups, improve breathing tests, or help children feel more in control of their asthma. This matters because many families wonder whether vitamin D — which is inexpensive and widely available — could help manage their child's asthma, and this large review of multiple studies suggests the benefit isn't proven yet. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · May 12, 2026
This study found that people with COPD or asthma who were given a concrete appointment at a smoking cessation clinic — booked right away during their doctor's visit, rather than just receiving general advice — were nearly twice as likely to have quit smoking a full year later (about 21% quit, compared to 12% who only got brief advice). The specific habit here is accepting or requesting an immediate, scheduled appointment with a quit-smoking specialist on the same day as a routine checkup, rather than leaving it as a vague plan to 'look into it later.' For people with COPD, quitting smoking is one of the most impactful steps for slowing the disease's progression and reducing flare-ups, and this study suggests that simply having a date on the calendar makes a meaningful difference in actually following through.
Ask your doctor: Ask the doctor whether getting an appointment right away at a smoking cessation clinic would help the patient quit smoking better than just getting advice.
Lifestyle
PubMed · May 10, 2026
This research looked at ways to help people with asthma or COPD (a long-term lung condition that makes breathing difficult) get vaccinated against flu and pneumonia more often, since many people with these conditions skip those vaccines. The studies found that the most effective approach was education — specifically, a healthcare professional (like a nurse or pharmacist) directly reminding and informing patients about why those vaccines matter for their lung health, which consistently led to more people actually getting vaccinated. The research doesn't point to a single food, exercise, or daily habit — the concrete action here is booking an appointment and asking your doctor or pharmacist to talk through the flu or pneumonia vaccine at the next visit.
Ask your doctor: Ask the doctor whether the patient should be getting the flu vaccine, pneumococcal vaccine, and COVID vaccine since the patient has asthma.
Lifestyle
PubMed · May 9, 2026
This large research review looked at 77 studies on teens and smoking, and found that adolescents who smoke — whether regular cigarettes or e-cigarettes — are noticeably more likely to have asthma than those who don't smoke at all. Even teens who don't smoke themselves but regularly breathe in smoke from parents, friends, or others nearby face a meaningfully higher asthma risk — and exposure to a friend's smoke showed the strongest link of all. One concrete thing that could matter starting today: avoiding spaces where others are smoking, since even secondhand smoke in a room or car is linked to worse asthma outcomes for young people.
Ask your doctor: Ask the doctor whether the patient's exposure to secondhand smoke at home or around friends could be making the patient's asthma worse or harder to control.
Medications
PubMed · May 1, 2026
This research looks at omalizumab (brand name Xolair), an injected medication used alongside other treatments for moderate-to-severe asthma — meaning asthma that is harder to control and more disruptive to daily life. The study reviewed what happened to patients after they stopped taking Xolair, and found that most people kept breathing well and felt about as good as they did while on it, without a major drop in their quality of life. This is a safety and outcomes update, giving doctors a clearer picture of what to expect when a patient stops this medication after a course of treatment.
Ask your doctor: Ask the doctor what the patient should expect if the patient ever need to stop taking omalizumab, and whether the patient's asthma symptoms might come back or change after stopping it.
What's New
PubMed · May 1, 2026
Researchers combined results from 11 studies and found that children with asthma were about 66% more likely to also have obstructive sleep apnea — a condition where breathing repeatedly stops and starts during sleep — compared to children without asthma. This is interesting because it suggests the two conditions may be connected in ways that aren't fully understood yet, and that paying closer attention to sleep problems in children with asthma might matter for their overall health someday. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · May 1, 2026
This study looked at a triple-combination asthma inhaler (containing beclometasone, formoterol, and glycopyrronium) that uses a newer, more eco-friendly propellant — the gas that pushes the medicine out of the inhaler. Researchers wanted to know if switching to this greener propellant was just as safe and well-tolerated as the current version, and the study found that it worked similarly, with no extra breathing problems and no increase in side effects. This is a safety update, suggesting the eco-friendly version of the inhaler appears to be a safe alternative to the existing one.
What's New
PubMed · May 1, 2026
Researchers tested a new pill called rilzabrutinib, which works by blocking a protein in the immune system that may drive the airway inflammation seen in asthma — think of it as trying to turn down a switch that keeps the immune system overreacting. In people with moderate-to-severe asthma whose symptoms weren't well controlled, the pill showed some promising signs of helping keep symptoms from getting worse. If this kind of approach holds up in larger studies down the road, it could someday offer a new option for people with hard-to-control asthma. This is early research and hasn't yet changed treatment guidelines.
Medications
PubMed · May 1, 2026
This research looked at what happens when people with severe asthma switch from one biologic medication (a type of targeted injected medicine that calms down specific parts of the immune system causing asthma) to a different one, such as moving from omalizumab to mepolizumab or benralizumab, or switching to newer options like dupilumab or tezepelumab. Across nearly 2,300 patients, the switch led to fewer serious asthma attacks, fewer emergency room visits, and better overall breathing and asthma control — most often because the first medication simply wasn't working well enough. This is a new option in the sense that this large review is confirming that switching biologics, rather than staying on one that isn't helping, appears to be a meaningful and effective strategy for people whose severe asthma remains hard to manage.
Lifestyle
PubMed · May 1, 2026
In this study, adults with asthma attended four one-on-one sessions with a nurse over four weeks — one 60-minute visit followed by three 45-minute visits — where they practiced proper inhaler technique, learned breathing exercises, and tried specific body positions to make breathing easier. Compared to people who received standard care, those who completed the program showed meaningfully better asthma control and quality of life after just four weeks. The sessions were led by a nurse in a primary care clinic, so anyone curious about this kind of structured support could ask your doctor whether a similar program is available nearby.
Lifestyle
PubMed · May 1, 2026
A study found that adults with asthma who did Nordic walking — a form of walking with two poles, similar to ski poles — three days a week for eight weeks were able to walk farther and spent more time doing vigorous physical activity compared to people who didn't do the program. Nordic walking is a low-impact exercise where the poles help engage the upper body while walking. Participants found it manageable and comfortable, and no one experienced any harmful side effects during the program.
What's New
PubMed · April 30, 2026
Researchers tested whether shining a special LED light on muscles before strength training sessions could help adults with hard-to-control asthma get stronger and breathe better — the idea being that the light might help muscles work more efficiently. They found that the group who got the light therapy along with their training showed greater improvements in muscle strength and exercise capacity than the group who did training alone, which is interesting because people with hard-to-control asthma often have weaker muscles that make everyday activities harder. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · April 24, 2026
Researchers looked at 10 studies and found that people with asthma tended to have thicker walls in a major neck artery (called the carotid artery) compared to people without asthma — and this was especially noticeable in children and teenagers. Thicker artery walls can be an early, silent sign that arteries are slowly hardening, which over many years can raise the risk of serious heart problems like heart attacks or strokes. If future research confirms this link, it could someday help doctors keep a closer eye on heart health in people with asthma — but this is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · April 17, 2026
Researchers tested whether sending doctors both a paper report and a digital report about their asthma prescribing habits would lead to better, greener inhaler choices compared to a digital report alone — but they found no significant difference between the two approaches. The idea behind the study was that some inhalers have a much larger carbon footprint than others, and nudging doctors toward lower-carbon options could be good for both patients and the planet. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · April 12, 2026
Researchers in China tried adding acupuncture — a practice where thin needles are placed at specific points on the body — to standard medical care for people having a flare-up of bronchial asthma, a lung condition that causes breathing difficulties. They found that the group receiving acupuncture alongside regular treatment showed greater improvements in breathing measurements and symptom scores compared to the group receiving standard treatment alone. This is an intriguing early finding, but the study was small and conducted over a short period, so it's far too soon to know whether acupuncture would reliably help people with asthma in a broader setting. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · April 12, 2026
Researchers tested whether adding a traditional Chinese medicine technique called 'wheat-grain moxibustion' — a form of heat therapy applied to specific points on the body — could help people with a type of asthma that mainly causes coughing. They found that people who received this therapy alongside standard medication showed greater improvement in their symptoms and lung function than those who took medication alone. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.